BlinkBio Competitors and Similar CompaniesClear all
BlinkBio's competitors and similar companies include RAPT Therapeutics, Karo Healthcare, Xilio Therapeutics and BioAtla.
 RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. |  Karo Healthcare Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors. |  Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. |  BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer. | ||
Founding Date | Founding Date 2009 | Founding Date 2015 | Founding Date 1987 | Founding Date 2015 | Founding Date 2007 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Jupiter, US HQ | Locations South San Francisco, US HQ | Locations Stockholm, SE HQ Stockholm, SE | Locations Waltham, US HQ | Locations San Diego, US HQ |
Employees | Employees 5 | Employees 64 | Employees 225 | Employees 69 | Employees 616% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 69.8 m | Valuation ($) N/A | Valuation ($) 43.5 m | Valuation ($) 100.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr3b (FY, 2021) | Revenue (est.) $43.8m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($129.9m) (FY, 2024) | Net income (kr17m) (FY, 2021) | Net income ($35m) (FY, 2025) | Net income ($59.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 176m | Total funding raised N/A | Total funding raised $ 233m | Total funding raised $ 186.5m |
For sources of this data, please see the company profile
View Company Profiles
RAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View companyKaro Healthcare
HQ
Stockholm, SE
Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.
View companyXilio Therapeutics
HQ
Waltham, US
Employees
69
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View companyBioAtla
HQ
San Diego, US
Employees
61↓ 6% decrease
BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.
View company